SPHERA FUNDS MANAGEMENT LTD. - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 70 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 1.0%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$950,000
-66.8%
500,000
+181.6%
0.20%
-47.8%
Q2 2019$2,858,000
-52.9%
177,546
-8.0%
0.39%
-29.4%
Q1 2019$6,074,000
-8.9%
192,994
-4.9%
0.55%
-26.2%
Q4 2018$6,666,000
-25.4%
202,994
-31.5%
0.75%
-26.8%
Q3 2018$8,935,000
+89.5%
296,251
+68.3%
1.03%
+57.8%
Q2 2018$4,716,000176,0450.65%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q4 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,283,966$15,166,0001.40%
Sio Capital Management, LLC 591,870$3,930,0000.98%
TFG Asset Management GP Ltd 2,500,000$16,600,0000.90%
Ikarian Capital, LLC 1,356,048$9,004,0000.73%
SABBY MANAGEMENT, LLC 400,050$2,656,0000.37%
Nantahala Capital Management 1,793,500$11,909,0000.34%
Regency Capital Management Inc.\DE 57,000$378,0000.29%
Eversept Partners, LP 473,074$3,141,2110.21%
MYDA Advisors LLC 85,000$564,0000.14%
Henry James International Management Inc. 54,047$359,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders